Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Chemical Biology|May 24, 2016
Structural analysis of human KDM5B guides histone demethylase inhibitor developmentCatrine Johansson, Srikannathasan Velupillai, Anthony Tumber, et al.Blood Cancer Journal|January 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myelomaKeiji Kurata, Anna James-Bott, Mark A Tye, et al.Cell Chemical Biology|March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma CellsAnthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.Blood Cancer Discovery|July 14, 2021
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple MyelomaHiroto Ohguchi, Paul M C Park, Tingjian Wang, et al.Journal of Medicinal Chemistry|September 25, 2019
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin FunctionVincent Fagan, Catrine Johansson, Carina Gileadi, et al.Journal of Medicinal Chemistry|January 8, 2016
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase InhibitorsVassilios Bavetsias, Rachel M Lanigan, Gian Filippo Ruda, et al.Biorxiv : the Preprint Server for Biology|April 1, 2021
The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 InfectionDaniel R Sandoval, Thomas Mandel Clausen, Chelsea Nora, et al.Pageof 4